Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Change in Inventory: 2022-2024

Historic Change in Inventory for Axsome Therapeutics (AXSM) over the last 3 years, with Dec 2024 value amounting to -$744,000.

  • Axsome Therapeutics' Change in Inventory rose 487.73% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 170.28%. This contributed to the annual value of -$744,000 for FY2024, which is 109.12% down from last year.
  • According to the latest figures from FY2024, Axsome Therapeutics' Change in Inventory is -$744,000, which was down 109.12% from $8.2 million recorded in FY2023.
  • Over the past 5 years, Axsome Therapeutics' Change in Inventory peaked at $8.2 million during FY2023, and registered a low of -$744,000 during FY2024.
  • For the 3-year period, Axsome Therapeutics' Change in Inventory averaged around $2.9 million, with its median value being $1.3 million (2022).
  • Its Change in Inventory has fluctuated over the past 5 years, first spiked by 512.77% in 2023, then slumped by 109.12% in 2024.
  • Axsome Therapeutics' Change in Inventory (Yearly) stood at $1.3 million in 2022, then surged by 512.77% to $8.2 million in 2023, then crashed by 109.12% to -$744,000 in 2024.